Skip to content

QuidelOrtho Corporation QDEL Granted (in dollars per share)

Granted (in dollars per share) at other companies

CHE
ChemedCHE
514.4-8.8%
DJT
Trump Media & Technology GroupDJT
$0.00
Belden logo
BeldenBDC
$120.25+33.6%
Cal-Maine Foods logo
Cal-Maine FoodsCALM
$101.14
General Motors logo
General MotorsGM
$50.88+21.8%
Repligen logo
RepligenRGEN
$125.03

Other financials

Income statement

See full
Revenue$619.8M-10.5%
Gross profit$263.8M-23.2%
Operating income-$31.8M-198%
Net income-$91.8M-623%
EPS (diluted)-$1.35-611%

Balance sheet

See full
Cash & equivalents$140.4M+10.4%
Total debt$3.1B+0.3%
Total equity$1.9B-38.2%
Total assets$5.6B-12.9%

Cash flow

See full
Operating cash flow-$33.0M-150%
CapEx$34.0M-39.5%
Free cash flow-$67.0M-813%

Valuation

See full
Market cap$921.94M-51.4%
Enterprise value$3.88B-20.1%
P/S0.4×-0.3×

Profitability

See full
Gross margin45%-2.0pp
Operating margin-37%-46.2pp
Net margin-45.6%-75.7pp
FCF margin13.8%

Returns & leverage

See full
Return on equity-49.9%-70.8pp
Debt / equity1.7×+0.6×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.

The official record: QuidelOrtho Corporation’s 10-K, filed February 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's granted (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QuidelOrtho Corporation's granted (in dollars per share)?
QuidelOrtho Corporation (QDEL) reported granted (in dollars per share) of $35.53 in Q4 2025.
What does granted (in dollars per share) mean?
The weighted average fair value at the grant date of non-option equity instruments awarded to employees during the period. This figure provides insight into the cost basis of equity incentives and the perceived value of the company's stock at the time of issuance.